IP Library Granted Patent US 7,872,118
Granted Patent B2
US 7,872,118 · App. 11/851,145 · Granted Jan 18, 2011

siRNA and methods of manufacture

Assignee: Opko Ophthalmics, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,872,118
App. No.
11/851,145
Granted
Jan 18, 2011
Kind
B2
Abstract

Double-stranded RNA of about 19 to about 25 nucleotides in length capable of regulating gene expression by RNA interference is provided. Such double-stranded RNA are particularly useful for treating disease or conditions associated with a target mRNA or gene. Methods of manufacture and methods of use of the double-stranded RNA are also provided.

Claims (18)

1. A method of preparing a double-stranded RNA molecule comprising

(a) synthesizing one RNA strand having a length from about 19 to about 25 nucleotides,

(b) synthesizing a second RNA strand and a third RNA strand, wherein the combined length of the second RNA strand and the third RNA strand is from about 19 to about 25 nucleotides;

(c) combining the synthesized RNA strands under conditions, wherein a double-stranded RNA molecule is formed, wherein the double-stranded RNA molecule consists of a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

2. The method according to claim 1 , wherein the RNA strands are chemically synthesized.

3. The method according to claim 1 , wherein the RNA strands are enzymatically synthesized.

4. The method of claim 1 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

5. The method of claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang from about 1 to about 5 nucleotides.

6. The method of claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang of about 2 nucleotides.

7. The method of claim 1 , wherein the one RNA strand has a length from about 20 to about 22 nucleotides and the combined length of the second RNA strand and the third RNA strand is from about 20 to about 22 nucleotides.

8. The method of claim 1 , wherein the double-stranded RNA molecule comprises at least one sugar-modified nucleotide, wherein the 2′—OH group of said sugar-modified nucleotide is replaced by a group selected from H, OR, R, halo, SH, SR, NH 2 , NHR, N(R) 2 or CN, wherein R is C 1 -C 6 alkyl, alkenyl or alkynyl and halo is F, Cl, Br or I.

9. The method of claim 1 , wherein the double stranded RNA molecule comprises at least one backbone-modified nucleotide containing a phosphorothioate group.

10. A method of preparing a double-stranded RNA molecule comprising

(a) synthesizing one RNA strand having a length from 25 or fewer nucleotides,

(b) synthesizing a second RNA strand and a third RNA strand, wherein the combined length of the second RNA strand and the third RNA strand is 25 or fewer nucleotides;

(c) combining the synthesized RNA strands under conditions, wherein a double-stranded RNA molecule is formed, wherein the double-stranded RNA molecule consists of a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

11. The method of claim 10 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule.

12. The method of claim 10 , wherein the one RNA strand has a length from 20-22 nucleotides and the combined length of the second RNA strand and the third RNA strand is from 20-22 nucleotides.

Assignments (5)
CHANGE OF NAME Recorded Jan 31, 2019
From: RXI PHARMACEUTICALS CORPORATION
To: PHIO PHARMACEUTICALS CORP
Reel/Frame 048860/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2015
From: OPKO PHARMACEUTICALS, LLC
To: RXI PHARMACEUTICALS CORPORATION
Reel/Frame 035527/0144 →
CHANGE OF NAME Recorded Oct 3, 2012
From: OPKO OPHTHALMICS, LLC.
To: OPKO PHARMACEUTICALS, LLC.
Reel/Frame 029068/0529 →
CHANGE OF NAME Recorded Nov 30, 2010
From: OPKO HEALTH, INC.
To: OPKO OPHTHALMICS, LLC
Reel/Frame 025522/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2008
From: REICH, SAMUEL JOTHAM; ENDEJANN, N. NICOLE
To: EXEGENICS, INC., D/B/A OPKO HEALTH, INC.
Reel/Frame 021641/0797 →
Continuity (2)
Provisional Application 6082495300 · Sep 8, 2006
Related Publication 20090061487A1 · Mar 5, 2009